메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

United Imaging Healthcare Reports 2025H1 Financial Results: Achieves Record Revenue in Overseas market

SHANGHAI, Aug. 29, 2025 -- United Imaging Healthcare (SSE: 688271), a global leader in advanced medical imaging and radiotherapy equipment, has released its financial results for the first half of 2025, maintaining steady growth. The company's revenue and net profit attributable to ordinary shareholders after deducting non-recurring profit or loss reached CNY 6.02 billion and 0.97 billion for 2025H1, representing a year-over-year increase of 12.79% and 21.01% respectively. The company's revenue growth was primarily fueled by continuous launch of innovative high-end products, now widely
- 김갑성 기자
- 2025-08-29 20:00
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

[ 메디채널 김갑성 기자 ] Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market on August 29, 2025, under the ticker symbols "YDES" and "YDESW" NEW YORK, Aug. 29, 2025 -- YD Bio Limited ("YD Bio Ltd" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the successful completio
- 김갑성 기자
- 2025-08-29 19:30
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025

DALLAS, Aug. 29, 2025 -- At Taiwan Expo USA 2025 in Dallas, the Smart Healthcare Pavilion, organized by the International Trade Administration (TITA) and the Taiwan External Trade Development Council (TAITRA), highlighted Taiwan's accelerating role in global digital health innovation. The pavilion brought together leading organizations introducing new approaches across telemedicine, artificial intelligence (AI), precision medicine, and next-generation medical services, as reported by GeneOnline. One key highlight was CancerFree Biotech Ltd., which has advanced precision oncolog
- 김갑성 기자
- 2025-08-29 17:32
MGI Tech and JCBio Announce Collaboration on DCS Lab Project to Advance Multi-Omics Innovation in South Korea

CHANGCHUN, China, Aug. 29, 2025 -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and JCBio Co., Ltd. ("JCBio"), a leading South Korean biotechnology company, have signed a Memorandum of Understanding (MoU) to launch the DCS Lab Project, a landmark collaboration. The initiative aims to accelerate multi-omics research, novel sequencing applications, precision medicine, clinical translation, and AI-driven data insights in South Korea. By combining MGI's advanced omics technologies with
- 김갑성 기자
- 2025-08-29 17:29
Gateway to Growth: Innovation and Opportunity at the 8th CIIE

SHANGHAI, Aug. 29, 2025 -- Amid a shifting global economy, the China International Import Expo (CIIE) continues to provide a vital gateway for global enterprises. With preparations for the 8th CIIE well underway, the expo is set to once again showcase innovation, foster cooperation, and expand access to the Chinese dynamic market. Leveraging the vital platform for global enterprises to access the Chinese massive market, many exhibitors have grown from participants into investors, while numerous exhibits have been transformed into marketable goods. Novartis, for instance, debute
- 김갑성 기자
- 2025-08-29 16:44
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

[ 메디채널 김갑성 기자 ] 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in children and adults with Dravet syndrome or Lennox-Gastaut syndrome[2] Data provide insights on developmental and epileptic encephalopathies (DEEs), including a qualitative study addressing diagnostic challenges and benefits in adult care settings, and a caregiver survey exploring the dai
- 김갑성 기자
- 2025-08-29 14:00
Alphamab Oncology Reports 2025 Interim Results and Business Highlights

SUZHOU, China, Aug. 29, 2025 -- Alphamab Oncology (stock code: 9966.HK) reported interim financial results for the six months ended June 30, 2025 and highlighted recent business progress. Financial Summary For the six months ended June 30, 2025, we recorded total revenue of RMB 319.44 million, an increase of 84.05% compared with the first half of 2024. Meanwhile, product revenue (attributed to the Company) amounted to RMB 67.02 million. For the six months ended June 30, 2025, our R&D expenditure amounted to RMB 253.16 million, an increase of 30.14% compared with the fir
- 김갑성 기자
- 2025-08-29 09:53
Mayapada Healthcare Holds Commencement Ceremony for an International Hospital in the Batam Tourism and International Healthcare SEZ

JAKARTA, Indonesia, Aug. 29, 2025 -- Mayapada Healthcare (IDX:SRAJ), the healthcare services arm of Mayapada Group, held a commencement ceremony to mark the development of its international-standard hospital, Mayapada Apollo Batam International Hospital (MABIH), located in Batam Tourism and International Healthcare Special Economic Zone (SEZ), Sekupang, Batam, Riau Islands. The ceremony was led by the Chairman of Batam Indonesia Free Trade Zone Authority (BP Batam), Amsakar Achmad. The ceremony marks a significant step in strengthening Indonesia's national healthcare ecosystem while reducing
- 김갑성 기자
- 2025-08-29 09:23
HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

SINGAPORE, Aug. 29, 2025 -- The JungKwanJang delegation included Kim Yang-jin, Director General of the Overseas Business Division; Jung Jong, Director General of the Asia-Pacific Business Division; and Kim Jong-sik, Director of the Future Business Research Institute, along with five other representatives. HEC Group was represented by Director and General Manager Tang Xinfa; Lu Yuxin, Director and General Coordinator of the Health Industry; Li Wenjia, Deputy General Coordinator of the Health Industry and Dean of the Health Research Institute; Chen Hao, General Manager of HEC Pharmacy C
- 김갑성 기자
- 2025-08-29 08:15
Everest Medicines Announces Interim Results for First Half of 2025

SHANGHAI, Aug. 29, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2025 along with a corporate update. "In the first half of 2025, Everest Medicines accelerated its transformation into a leading global biopharmaceutical company by deepening our 'dual-engine' strategy," commented Rogers Yongqing Luo, CEO of Everest Medicines. "We have built a co
- 김갑성 기자
- 2025-08-29 07:52

이전

71 72 73 74 75 76 77 78 79 80

많이 본 기사

최근기사

2025-11-05_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 09시 20분